145 related articles for article (PubMed ID: 21607046)
1. Bolus fluorouracil induced syncope and pulseless ventricular tachycardia: a case report.
Fidan E; Fidan S; Yildiz B; Durmus I; Kavgaci H; Ozdemir F; Aydin F
Hippokratia; 2011 Jan; 15(1):93-5. PubMed ID: 21607046
[TBL] [Abstract][Full Text] [Related]
2. Ventricular fibrillation cardiac arrest due to 5-fluorouracil cardiotoxicity.
Fradley MG; Barrett CD; Clark JR; Francis SA
Tex Heart Inst J; 2013; 40(4):472-6. PubMed ID: 24082383
[TBL] [Abstract][Full Text] [Related]
3. A Case of 5-Fluorouracil-Induced Cardiac Arrest.
Ray JC; Cho P; Dragon M; Graham CG
J Emerg Med; 2016 Jan; 50(1):e1-6. PubMed ID: 26482827
[TBL] [Abstract][Full Text] [Related]
4. Successful infusional 5-fluorouracil administration in a patient with vasospastic angina.
Tai S; Mohananey D; Griffiths C; Johnson B; Garg J; Ridolfi TJ; Lohr NL; Chakrabarti S; Brown SA
Am Heart J Plus; 2022 May; 17():. PubMed ID: 36051246
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and Management of a Patient With 5-Fluorouracil-Induced ST Elevation and Nonsustained Ventricular Tachycardia as a Late Presentation of Cardiotoxicity and Successful 5-Fluorouracil Rechallenge.
Medepalli LC; Mahmood TS; Liberman H; Medepalli AM; Bagwell TW
Cureus; 2022 Oct; 14(10):e30489. PubMed ID: 36415417
[TBL] [Abstract][Full Text] [Related]
6. ST-Segment Elevation Myocardial Infarction Caused by 5-Fluorouracil-Related Cardiotoxicity.
Balaji N; Dixit P; Adams AM; Faiz F; Ngwainmbi D; Henry G; Ghasemzadeh N
Cureus; 2024 Jan; 16(1):e52864. PubMed ID: 38406077
[TBL] [Abstract][Full Text] [Related]
7. Reintroduction of 5-Fluorouracil Post-cardiac Arrest Secondary to Chemotherapy-Induced Cardiotoxicity.
Wu K; Bhattacharya P
Cureus; 2023 Jan; 15(1):e34232. PubMed ID: 36852353
[TBL] [Abstract][Full Text] [Related]
8. Clinical cardiotoxicity of 5-fluorouracil.
Keefe DL; Roistacher N; Pierri MK
J Clin Pharmacol; 1993 Nov; 33(11):1060-70. PubMed ID: 8300889
[TBL] [Abstract][Full Text] [Related]
9. Bolus 5-fluorouracil (5-FU) In Combination With Oxaliplatin Is Safe and Well Tolerated in Patients Who Experienced Coronary Vasospasm With Infusional 5-FU or Capecitabine.
Chakrabarti S; Sara J; Lobo R; Eiring R; Finnes H; Mitchell J; Hartgers M; Okano A; Halfdanarson T; Grothey A
Clin Colorectal Cancer; 2019 Mar; 18(1):52-57. PubMed ID: 30396850
[TBL] [Abstract][Full Text] [Related]
10. Coronary vasospasm secondary to 5-Fluorouracil and its management: case report.
Yildirim M; Parlak C; Sezer C; Eryilmaz R; Kaya C; Yildiz M
Eurasian J Med; 2011 Apr; 43(1):54-6. PubMed ID: 25610161
[TBL] [Abstract][Full Text] [Related]
11. Capecitabine-Associated Coronary Vasospasm and Cardiac Arrest.
Muco E; Patail H; Shaik A; McMahon S
Cureus; 2022 Aug; 14(8):e28184. PubMed ID: 36158449
[TBL] [Abstract][Full Text] [Related]
12. Bolus 5-Fluorouracil as an alternative modality to infusion 5-Fluorouracil in a patient with rectal cancer and capecitabine-induced cardiotoxicity.
Shaib W; Lee V; Saif MW
In Vivo; 2009; 23(5):821-6. PubMed ID: 19779118
[TBL] [Abstract][Full Text] [Related]
13. Ventricular fibrillation as a likely consequence of capecitabine-induced coronary vasospasm.
Shah NR; Shah A; Rather A
J Oncol Pharm Pract; 2012 Mar; 18(1):132-5. PubMed ID: 21321041
[TBL] [Abstract][Full Text] [Related]
14. Capecitabine-induced-coronary-vasospasm leading to polymorphic ventricular tachycardia and cardiac arrest.
Kabat M; Padalkar R; Hazaveh S; Joseph V; Feigenblum D; Sadikot S
Cardiooncology; 2024 Feb; 10(1):11. PubMed ID: 38414072
[TBL] [Abstract][Full Text] [Related]
15. 5-Fluorouracil Rechallenge After Cardiotoxicity.
Desai A; Mohammed T; Patel KN; Almnajam M; Kim AS
Am J Case Rep; 2020 Aug; 21():e924446. PubMed ID: 32860674
[TBL] [Abstract][Full Text] [Related]
16. Cardiotoxicity related to 5-fluorouracil chemotherapy: a report of two cases.
Weng MC; Wang WB; Chao TY
Zhonghua Yi Xue Za Zhi (Taipei); 1995 Mar; 55(3):266-9. PubMed ID: 7780886
[TBL] [Abstract][Full Text] [Related]
17. Capecitabine-induced coronary artery vasospasm in a patient who previously experienced a similar episode with fluorouracil therapy.
Karakulak UN; Aladağ E; Maharjan N; Övünç K
Turk Kardiyol Dern Ars; 2016 Jan; 44(1):71-4. PubMed ID: 26875134
[TBL] [Abstract][Full Text] [Related]
18. Various Manifestations of 5-Fluorouracil Cardiotoxicity: A Multicenter Case Series and Review of Literature.
Allison JD; Tanavin T; Yang Y; Birnbaum G; Khalid U
Cardiovasc Toxicol; 2020 Aug; 20(4):437-442. PubMed ID: 31925673
[TBL] [Abstract][Full Text] [Related]
19. Secondary ventricular fibrillation or pulseless ventricular tachycardia during cardiac arrest and epinephrine dosing.
Straznitskas AD; Wong S; Kupchik N; Carlbom D
Am J Crit Care; 2015 May; 24(3):e22-7. PubMed ID: 25934728
[TBL] [Abstract][Full Text] [Related]
20. Cardiotoxicity of high-dose continuous infusion fluorouracil: a prospective clinical study.
de Forni M; Malet-Martino MC; Jaillais P; Shubinski RE; Bachaud JM; Lemaire L; Canal P; Chevreau C; Carrié D; Soulié P
J Clin Oncol; 1992 Nov; 10(11):1795-801. PubMed ID: 1403060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
